Introduction
Ambulatory blood pressure measurement, which has been confined to research for many years, is now an accepted investigation in clinical practice [ l ] . In an effort to ensure that the devices meet the requirements of clinical practice the British Hypertension Society (BHs) has published a comprehensive protocol for the evaluation of blood pressure measuring devices with special reference to ambulatory systems [2] . Four ambulatory systems, the SpaceIabs 90207 
Methods
The BHS evaluation consisted of six phases: I, Observer training and assessment; 11, Before-use interdevice variability assessment; 111, In-use (field) assessment; IV, After-use interdevice variability assessment; V, Device validation; and VI, Report of evaluation [2] .
The accuracy of the devices was tested in the laboratory by comparing sequential blood pressure measurements obtained from the same arm in 86 subjects with a wide range of blood pressure [ M ] . The percentage of measurements differing from the mercury standard by 5, 10 and 15mmHg or less is shown in Table 1 .
The devices were graded A, B, C or D according to the BHS criteria set out in Table 1 . The Association for the Advancement of Medical Instrumentation (AAMI) [7] has stipulated that the mean difference between a test device and mercury sphygrnomanometer should not be greater than 5 mmHg, with a standard deviation not greater than 8mmHg for both systolic and diastolic pressures. These criteria were also applied to the validation data of the four systems. 
